297 related articles for article (PubMed ID: 34637688)
1. MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1.
Li Y; Yao N; Gao Y; Wang Y; Bai L; Xu J; Wang H
Bioengineered; 2021 Dec; 12(1):8555-8569. PubMed ID: 34637688
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of TXNIP contributes to granulosa cell dysfunction in polycystic ovary syndrome via activation of the NLRP3 inflammasome.
Wang Y; Yang J; Wang Y; Chen Y; Wang Y; Kuang H; Feng X
Mol Cell Endocrinol; 2023 Feb; 561():111824. PubMed ID: 36450326
[TBL] [Abstract][Full Text] [Related]
3. miR-146a-5p Attenuates Allergic Airway Inflammation by Inhibiting the NLRP3 Inflammasome Activation in Macrophages.
Yang Y; Huang G; Xu Q; Zhao G; Jiang J; Li Y; Guo Z
Int Arch Allergy Immunol; 2022; 183(9):919-930. PubMed ID: 35660690
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome.
Liu Y; Zhang S; Chen L; Huang X; Wang M; Ponikwicka-Tyszko D; Rahman NA; Wolczynski S; Yao B; Li X
Transl Res; 2023 Jun; 256():1-13. PubMed ID: 36586536
[TBL] [Abstract][Full Text] [Related]
5. NF-κB inducible miR-30b-5p aggravates joint pain and loss of articular cartilage via targeting SIRT1-FoxO3a-mediated NLRP3 inflammasome.
Xu H; Zhang J; Shi X; Li X; Zheng C
Aging (Albany NY); 2021 Aug; 13(16):20774-20792. PubMed ID: 34455406
[TBL] [Abstract][Full Text] [Related]
6. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome.
Kim DH; Kim SM; Lee B; Lee EK; Chung KW; Moon KM; An HJ; Kim KM; Yu BP; Chung HY
J Nutr Biochem; 2017 Jul; 45():104-114. PubMed ID: 28499186
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response.
Huang X; Luo X; Huang S; Chen X; Qiu L
Funct Integr Genomics; 2024 Jan; 24(1):6. PubMed ID: 38189995
[TBL] [Abstract][Full Text] [Related]
8. HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis.
Chen J; Zhu Z; Xu S; Li J; Huang L; Tan W; Zhang Y; Zhao Y
Mol Cell Endocrinol; 2023 Aug; 573():111950. PubMed ID: 37207962
[TBL] [Abstract][Full Text] [Related]
9. Bushenhuoluo Decoction improves polycystic ovary syndrome by regulating exosomal miR-30a-5p/ SOCS3/mTOR/NLRP3 signaling-mediated autophagy and pyroptosis.
Huang Q; Li Y; Chen Z; Ou H; Tan Y; Lin H
J Ovarian Res; 2024 Feb; 17(1):29. PubMed ID: 38302986
[TBL] [Abstract][Full Text] [Related]
10. Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis.
Xu X; Xu X; Wang X; Shen L
Pharm Biol; 2023 Dec; 61(1):878-885. PubMed ID: 37272921
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
12. Circ_FURIN knockdown assuages Testosterone-induced human ovarian granulosa-like tumor cell disorders by sponging miR-423-5p to reduce MTM1 expression in polycystic ovary syndrome.
Xu X; Guan R; Gong K; Xie H; Shi L
Reprod Biol Endocrinol; 2022 Feb; 20(1):32. PubMed ID: 35177076
[TBL] [Abstract][Full Text] [Related]
13.
Chen H; Qiao H; Zhao Q; Wei F
Bioengineered; 2022 Mar; 13(3):4658-4673. PubMed ID: 35148667
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rd attenuates cerebral ischemia/reperfusion injury by exerting an anti-pyroptotic effect via the miR-139-5p/FoxO1/Keap1/Nrf2 axis.
Yao Y; Hu S; Zhang C; Zhou Q; Wang H; Yang Y; Liu C; Ding H
Int Immunopharmacol; 2022 Apr; 105():108582. PubMed ID: 35124564
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-135b alleviates MPP
Zeng R; Luo DX; Li HP; Zhang QS; Lei SS; Chen JH
J Clin Neurosci; 2019 Jul; 65():125-133. PubMed ID: 31036506
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of NLRP3 inflammasome-A potential mechanistic therapeutic for treatment of polycystic ovary syndrome?
Chamanara S; Hozouri V; Irandoost E
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23592. PubMed ID: 38054794
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 Inflammasome-dependent Pathway is Involved in the Pathogenesis of Polycystic Ovary Syndrome.
Wang B; Shi M; Yu C; Pan H; Shen H; Du Y; Zhang Y; Liu B; Xi D; Sheng J; Huang H; Ding G
Reprod Sci; 2024 Apr; 31(4):1017-1027. PubMed ID: 37815748
[TBL] [Abstract][Full Text] [Related]
18. IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats.
Chen D; Dixon BJ; Doycheva DM; Li B; Zhang Y; Hu Q; He Y; Guo Z; Nowrangi D; Flores J; Filippov V; Zhang JH; Tang J
J Neuroinflammation; 2018 Feb; 15(1):32. PubMed ID: 29394934
[TBL] [Abstract][Full Text] [Related]
19. Follicular fluid-derived exosomal miR-143-3p/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome.
Cao J; Huo P; Cui K; Wei H; Cao J; Wang J; Liu Q; Lei X; Zhang S
Cell Commun Signal; 2022 May; 20(1):61. PubMed ID: 35534864
[TBL] [Abstract][Full Text] [Related]
20. Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling.
Li H; Li Y; Zhang Y; Tong L; Sa Y; Sun W
Gynecol Endocrinol; 2023 Jul; 39(1):2237116. PubMed ID: 37489849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
